A group of U.S. Senators is attempting to end the prohibition-fueled dearth of federal cannabis research. The Senate Appropriations Committee has made a series of directives to the National Institute of Drug Abuse (NIDA) and Drug Enforcement Agency (DEA) that could create national standards for cannabis product safety.
Because marijuana is still illegal on the federal level, research has into the plant has been severely lacking. According to a report from long-time cannabis advocate Tom Angell for Forbes, the Appropriations Committee released a report this week that instructs scientists at the two federally funded drug agencies to remedy that problem, requesting the creation of a “National Testing Program for Schedule I Marijuana-Derived Products.”
In their recommendations, the committee calls for the testing of both cannabis seized in DEA drug busts and cannabis products available commercially in legal weed states. It is still not clear whether the legal weed products included in the recommendations would be purchased from licensed dispensaries or seized in DEA raids.
“The Committee believes that such research [on law-enforcement-seized cannabis], along with analysis…